Back to Webinars
Biomarker Strategies for Optimizing Checkpoint Immunotherapy Treatment

Featured Speaker: Naval Daver, PhD, Associate Professor, Department of Leukemia, MD Anderson Cancer Center

Your data is secure. We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from Bruker Cellular Analysis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Webinar we discuss:

Review advanced immune-based approaches in acute myeloid leukemia that combine chemotherapy with checkpoint therapy

Explore relevant biomarker strategies associated with these approaches

See how single-cell cytokine analysis system and PSI demonstrate that specific cytokine potency contributors correlate with overall survival

Watch the Webinar